# FDA Inspection 1219529 - Wanbang Biopharmaceuticals - September 08, 2023

Source: https://www.keypedia.com/records/fda_inspections/wanbang-biopharmaceuticals/eb0257cf-af2b-441d-871e-6d531adbefbb
Source feed: FDA_Inspections

> FDA inspection 1219529 of Wanbang Biopharmaceuticals, September 08, 2023. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219529
- Company Name: Wanbang Biopharmaceuticals
- Inspection Date: 2023-09-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/wanbang-biopharmaceuticals/06ce9dd3-f258-4095-ab7d-df66357273c3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c